| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385847A2 Pyrazolo[1,5-a]pyridine derivatives |
| 02/04/2004 | EP1385846A2 Synthesis of pancratistatin prodrugs |
| 02/04/2004 | EP1385844A1 Oxazolidinones containing a sulfonimid group as antibiotics |
| 02/04/2004 | EP1385843A1 Arylindenopyridines with pde inhibiting activity |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385834A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 02/04/2004 | EP1385830A1 Sulfonamides |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385821A2 Novel anti-adhesive compounds and uses thereof |
| 02/04/2004 | EP1385554A2 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 02/04/2004 | EP1385542A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 02/04/2004 | EP1385538A2 Chimeric vaccines |
| 02/04/2004 | EP1385534A2 Ccr5 antagonist and dp-178 polypeptide for treating viral infections |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385511A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385502A2 Method for the production of anhydrous, pharmaceutical formulations of xanthogenates |
| 02/04/2004 | EP1385498A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 02/04/2004 | EP1385496A2 Use of compositions for treating rosacea |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385482A1 An effervescent solid composition of matter |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1385475A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same |
| 02/04/2004 | EP1385452A1 Ophthalmic drug delivery device |
| 02/04/2004 | EP1257304B1 Foam-forming wound dressing |
| 02/04/2004 | EP1196409B1 Respiratory syncytial virus replication inhibitors |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP1021196B1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 02/04/2004 | EP1007055B1 Use of amifostine |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473160A Indole derivatives as medicinal compositions for antifungal and/or antiparasitic agents |
| 02/04/2004 | CN1473157A 酰胺衍生物 Amide derivatives |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1472336A SARS coronavirus 3Cl protease two-dimensional model and medicine preventing SARS |
| 02/04/2004 | CN1472332A Target for medicine against Sars-Cov and medicine screening method and medicine against Sars |
| 02/04/2004 | CN1472327A Fermentation of antifungal antibiotic produced by oceanic bacillus |
| 02/04/2004 | CN1472326A Metabolist product of cyathus against mycobacterium tuberculosis and preparation thereof |
| 02/04/2004 | CN1472319A Method of expressing thymys peptide alpha by yeast and use thereof |
| 02/04/2004 | CN1472208A Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/04/2004 | CN1471981A Surface treatment for SARS lungs bacteria infection |
| 02/04/2004 | CN1471970A Recombination low-dosage human alpha-2b(IFN-alpha-2b) interferon lozenge and preparing method thereof |
| 02/04/2004 | CN1471960A Preparation of xinxue granules |
| 02/04/2004 | CN1471953A Medicinal plant composition for treating AIDS patient |
| 02/04/2004 | CN1471939A Medicine for treating virus infectious diarrhoea |
| 02/04/2004 | CN1471920A Compound antimicrobial medicine containing N-acetophenetidin-D-chitosamine |
| 02/04/2004 | CN1471916A Medicnial composition containing biphenyl lambral for treating superficial mycosis |
| 02/04/2004 | CN1471915A Powder injection of diflucan and its preparing method |
| 02/04/2004 | CN1471914A Medicine, application and preparing method for preventnig SARS pneumonia by SARS virus |
| 02/04/2004 | CN1137129C Schizophyllary tetrasaccharide cluster compound and its preparing method and use |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/04/2004 | CN1136918C Vaccines |
| 02/04/2004 | CN1136915C Use of nona-and decapeptides in the preparation of drug for treatment of aids |
| 02/04/2004 | CN1136907C Making process of enzume degrading oral liquid |
| 02/04/2004 | CN1136900C Medicine for treating pulmonary tuberculosis and its preparing process |
| 02/04/2004 | CN1136894C Medicinal composition for treating tuberculosis and its preparing process |
| 02/04/2004 | CN1136889C Instant particles as Chinese medicine for treating AIDS and its preparing process |
| 02/04/2004 | CN1136887C Exterior-applied medicine for treating dermatopathy |
| 02/04/2004 | CN1136879C Combined Chinese and Western medicine for treating chronic bronchitis in catabasis |
| 02/04/2004 | CN1136867C Antivirus compound medicine |
| 02/04/2004 | CN1136861C 'Lifeiqing' capsule for treating pulmonary tuberculosis |
| 02/04/2004 | CN1136859C Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 02/04/2004 | CN1136852C Pharmaceutical formulations of cefaclor |
| 02/04/2004 | CN1136849C Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 02/04/2004 | CN1136848C Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HTV medicine |
| 02/04/2004 | CN1136846C Formaldehyde injection for treating infective disease of animal |
| 02/04/2004 | CN1136844C Anti-AIDS medicine composition and its application |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686363 Effective against multi-resistant bacteria |
| 02/03/2004 | US6686356 Pyridoquinoxaline antivirals |
| 02/03/2004 | US6686341 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685973 Soybean extract to treat cardiovascular disorder |
| 02/03/2004 | US6685969 Treatment for ectoparasites |
| 02/03/2004 | US6685950 Methods of treating viral infections |
| 02/03/2004 | US6685946 Cold-adapted equine influenza viruses |
| 02/03/2004 | US6685937 Administering an effective amount of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for said bacteria to the site of the infection |
| 02/03/2004 | US6685935 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/03/2004 | US6685931 Treatment of hepatitis C virus infections with interleukin-10 |
| 02/03/2004 | US6685911 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/31/2004 | CA2425568A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 01/29/2004 | WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor |
| 01/29/2004 | WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 01/29/2004 | WO2004009800A1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/29/2004 | WO2004009784A2 Novel inhibitors of kinases |
| 01/29/2004 | WO2004009641A1 aPC NON-NEUTRALIZING ANTIBODY |
| 01/29/2004 | WO2004009601A1 Azaindole kinase inhibitors |